What is UroGen Pharma's investment proceeds?

UroGen Pharma (URGN) reported investment proceeds of $4.15M in Q1 2026.

How has UroGen Pharma's investment proceeds changed year-over-year?

UroGen Pharma's investment proceeds decreased by 89.7% year-over-year, from $40.43M to $4.15M.

What is the long-term trend for UroGen Pharma's investment proceeds?

Over 3 years (2022 to 2025), UroGen Pharma's investment proceeds has grown at a 29.3% compound annual growth rate (CAGR), from $64.41M to $139.25M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

UroGen Pharma URGN Investment Proceeds

Investment Proceeds at other companies

ImmunityBio, Inc.IBRX

$79.38M+1,384%

CG OncologyCGON

$252.85M+26.3%

ImmunomeIMNM

$0-100%

Ultragenyx PharmaceuticalRARE

$88M-35.8%

Krystal Biotech, Inc.KRYS

$103.6M+16.7%

Jazz PharmaceuticalsJAZZ

$520M+67.7%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's investment proceeds?: UroGen Pharma (URGN) reported investment proceeds of $4.15M in Q1 2026.
How has UroGen Pharma's investment proceeds changed year-over-year?: UroGen Pharma's investment proceeds decreased by 89.7% year-over-year, from $40.43M to $4.15M.
What is the long-term trend for UroGen Pharma's investment proceeds?: Over 3 years (2022 to 2025), UroGen Pharma's investment proceeds has grown at a 29.3% compound annual growth rate (CAGR), from $64.41M to $139.25M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.